Dr. Boris Dinkov is a physician, endocrinology resident, and Assistant Professor of Pharmacology and Clinical Pharmacology at the Department of Pharmacology, Medical University–Pleven, Bulgaria. He graduated from the Medical University–Pleven in 2021 as the valedictorian of his graduating class, receiving the prestigious Golden Hippocrates Award in recognition of his outstanding academic achievements and excellence in medical education. Since 2022, Dr. Dinkov has been pursuing postgraduate specialization in Endocrinology and Metabolic Diseases, while contributing to the academic and educational activities of the Department of Pharmacology as an Assistant Professor of Pharmacology and Clinical Pharmacology. His scientific interests lie at the intersection of endocrinology, metabolic medicine, and pharmacology, with a particular focus on type 2 diabetes, obesity, GLP-1-based pharmacotherapies, the gut microbiome, and hepatic dysfunction associated with diabetes. His research interests encompass the mechanisms of action, therapeutic applications, and emerging challenges of innovative pharmacological approaches to metabolic disease. Dr. Dinkov is particularly interested in the evolving landscape of GLP-1-based therapies and their broader implications for metabolic health, including the complex interplay between pharmacological treatment, intestinal physiology, microbiome-mediated processes, and liver function